E-cadherin expression as a differentiation marker in gastric cancer

Hepato-Gastroenterology

Volumn 45, Issue 24, 1998, Pages 2437-2442

  Karayiannakis, Anastasios J ^a,e   Syrigos, Konstantinos N ^b   Chatzigianni, Emmy ^c   Papanikolaou, Spilios ^a   Karatzas, Gabriel ^d  

^a 1st IKA Hospital   (Greece)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c 3rd IKA Hospital   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e NONE   (Greece)

Author keywords

Cell adhesion; E cadherin; Gastric cancer

Indexed keywords

UVOMORULIN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH MUCOSA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ANTIGENS, DIFFERENTIATION; CADHERINS; GASTRIC MUCOSA; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032427105     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Takeichi M: Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995; 7:619-627.
2. Gumbiner BM, McCrea PD: Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci 1993; 17(Suppl):155-158.
3. Hinck L, Nathke IS, Papkoff J, Nelson WJ: Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994; 125:1327-1340.
4. Frixen UH, Behrens J, Sachs M, et al: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113:173-185.
5. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, Van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66:107-119.
6. Jankowski JA, Newham PM, Kandemir O, Hirano S, Takeichi M, Pignatelli M: Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: a putative biomarker. Int J Oncol 1994; 4:441-448.
7. Gagliardi G, Kandemir O, Liu D, et al: Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virchows Arch 1995; 426:149-154.
8. Syrigos KN, Krausz T, Waxman J, et al: E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer 1995; 64:367-370.
9. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ: Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 1996; 105:394-402.
10. Oka H, Shiozaki H, Kobayashi K, et al: Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch [A] Pathol Anat Histopathol 1992; 421:149-156.
11. Yonemura Y, Nojima N, Kaji M, et al: E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer 1995; 76:941-953.
12. Mayer B, Johnson JP, Leitl F, et al: E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53:1690-1695.
13. Gabbert HE, Mueller W, Schneiders A, et al: Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 1996; 69:184-189.
14. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJG: Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterol 1997; 112:46-54.
15. Lauren P: The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
16. Oota K, Sobin LH: Histological typing of gastric and oesophageal tumours. International histological classification of tumours. No. 18. Geneva: World Health Organization, 1977.
17. Kennedy BJ: The unified international gastric cancer staging classification system. Scand J Gastroenterol 1987; 22(Suppl 133):11-13.
18. Oda T, Kanai Y, Oyama T, et al: E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 1994; 91:1858-1862.
19. Becker KF, Atkinson MJ, Reich U, et al: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54:3845-3852.
20. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N, Niitsu Y: Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 1995; 15:1175-1181.
21. Matsui S, Shiozaki H, Inoue M, et al: Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer. Virchows Arch 1994; 424:375-381.
22. Takeshima E, Hamaguchi M, Watanabe T, et al: Aberrant elevation of tyrosine-specific phosphorylation in human gastric cancer cells. Jpn J Cancer Res 1991; 82:1428-1435.
23. Hoschuetzky H, Aberle H, Kemler R: β-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 1994; 127:1375-1380.
24. Ochiai A, Akimoto S, Kanai Y, Shibata T, Oyama T, Hirohashi S: c-erbB-2 gene product associates with catenins in human cancer cells. Biochem Biophys Res Commun 1994; 205:73-78.
25. Lemoine NR, Jain S, Silvestre F, et al: Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. Br J Cancer 1991; 64:79-83.
26. Shibamoto S, Hayakawa M, Takeuchi K, et al: Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun 1994; 1:295-305.
27. Rubinfeld B, Souza B, Albert I, Munemitsu S, Polakis P: The APC protein and E-cadherin form similar but independent complexes with α-catenin, β-catenin, and plakoglobin. J Biol Chem 1995; 270:5549-5555.
28. Nakatsuru S, Yanagisawa A, Ichii S, et al: Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1992; 1:559-563.
29. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P: Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 1995; 92:3046-3050.
30. Morin PJ, Sparks AB, Korinek V, et al: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997; 275:1787-1790.
31. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P: Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997; 275:1790-1792.
32. Behrens J, von Kries JP, Kuhl M, et al: Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996; 382:638-642.
33. Pignatelli M: E-cadherin: a biological marker of tumour differentiation. J Pathol 1993; 171:81-82.